BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38601756)

  • 1. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
    Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
    Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
    Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study.
    Carr MJ; Steeg S; Webb RT; Kapur N; Chew-Graham CA; Abel KM; Hope H; Pierce M; Ashcroft DM
    Lancet Public Health; 2021 Feb; 6(2):e124-e135. PubMed ID: 33444560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
    Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
    JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: A population-based cohort study.
    Raventós B; Abellan A; Pistillo A; Reyes C; Burn E; Duarte-Salles T
    Int J Eat Disord; 2023 Jan; 56(1):225-234. PubMed ID: 36352763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
    Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
    Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study.
    Mansfield KE; Mathur R; Tazare J; Henderson AD; Mulick AR; Carreira H; Matthews AA; Bidulka P; Gayle A; Forbes H; Cook S; Wong AYS; Strongman H; Wing K; Warren-Gash C; Cadogan SL; Smeeth L; Hayes JF; Quint JK; McKee M; Langan SM
    Lancet Digit Health; 2021 Apr; 3(4):e217-e230. PubMed ID: 33612430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
    Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
    Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
    O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
    Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
    Tran C; Cipriano LE; Driman DK
    CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population-based study.
    Trafford AM; Carr MJ; Ashcroft DM; Chew-Graham CA; Cockcroft E; Cybulski L; Garavini E; Garg S; Kabir T; Kapur N; Temple RK; Webb RT; Mok PLH
    Lancet Child Adolesc Health; 2023 Aug; 7(8):544-554. PubMed ID: 37352883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.
    Gheorghe A; Maringe C; Spice J; Purushotham A; Chalkidou K; Rachet B; Sullivan R; Aggarwal A
    Eur J Cancer; 2021 Jul; 152():233-242. PubMed ID: 34049776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
    Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
    Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.